Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients-Reference-Cited by-同舟云学术

Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients

Published:2012-01-09 Issue:2 Volume:103 Page:288-295
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Li Meng,Xu Tianjiao,Zhang Zhao,Xue Xiaochang,Zhang Cun,Qin Xin,Li Weina,Hao Qiang,Zhang Wei,Zhang Yingqi

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2011.02153.x/fullpdf

Reference29 articles.

1. TNF: a moonlighting protein at the interface between cancer and infection;Hundsberger;Front Biosci,2008

2. Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor;Creasey;Cancer Res,1986

3. Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro;Sugarman;Science,1985

4. The TNF and TNF receptor superfamilies: integrating mammalian biology;Locksley;Cell,2001

5. The pathophysiologic role of cachectin/TNF in septic shock and cachexia;Tracey;Ann Inst Pasteur Immunol,1988

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal cancer: signaling pathways and advances in targeted therapies;MedComm;2024-08

2. Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer;Frontiers in Pharmacology;2023-02-15

3. Importance of TNF-alpha and its alterations in the development of cancers;Cytokine;2020-06

4. Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis;Experimental Biology and Medicine;2020-02-10

5. Immunomodulatory Therapies for Renal Cell Carcinoma;Protein & Peptide Letters;2018-08-28